Company:  ATARA BIOTHERAPEUTICS, IN ... (ATRA)
Form Type:  S-8
Filing Date:  2/27/2020 
CIK:  0001604464 
Address:  611 GATEWAY BLVD
SUITE 900
 
City, State, Zip:  SOUTH SAN FRANCISCO, California 94080 
Telephone:  650-278-8930 
Fiscal Year:  12/31 
Last Trade
Last Trade: 
$9.67  
Change: 
-0.905 (-8.56%)  
Trade Time: 
Jun 04  
Market Cap: 
$691.87M
Trade ATRA now with 

© 2020  
Description of Business
Atara Biotherapeutics is a leading off-the-shelf, allogeneic T-cell immunotherapy company that is developing novel treatments for patients with cancer, autoimmune and viral diseases. We have several T-cell immunotherapies in clinical development and are progressing a next-generation allogeneic chimeric antigen receptor T-cell, or CAR T program.
Register and access this filing in:     
  FORM S-8
    CALCULATION OF REGISTRATION FEE
    EXPLANATORY NOTE
    PART II
      ITEM 3. INCORPORATION OF CERTAIN DOCUMENTS BY REFERENCE
      ITEM 8. EXHIBITS
    SIGNATURES
  EXHIBIT 5.1
  EXHIBIT 23.2
    CONSENT OF INDEPENDENT REGISTERED PUBLIC ACCOUNTING FIRM